Using a recently described technique for direct expansion of human T-lymphocytes isolated from small intestine biopsies, we have investigated the local cellular immune response in six patients with B-cell lymphomas of various subtypes. T-cell lines (TCL) were established by seeding tumor-infiltrating T-lymphocytes (TITL) at limiting dilution in the presence of irradiated feeder cells in culture medium containing rIl-2 and phytohemagglutinin (PHA). About l/5o T-cells gave rise to a TCL; they all were CD3+. The CD4/ CD8 ratio was 3.8:1 before and after cloning. 
Introduction
Tumor-infiltrating leukocytes, which are usually found in neoplastic tissue, have attracted the interest of many immunologists (1) . Among the components of the lymphoreticular infiltrate of malignancies, macrophages have been studied most extensively. Other researchers are looking for tumor-specific monoclonal antibodies in order to trace tumor-associated antigens and for therapeutical reasons. However, T-lymphocytes represent the major component of these infiltrates. The greatly increased incidence of lymphomas in circumstances of immunosuppression (2) (3) (4) has prompted us to study the role of T-lymphocytes infiltrating human B-cell lymphomas. In view of the compartmentalization of T-cell immunity, it is possible that the relevant Tcells may be sequestered into the malignant lesion (5) . Therefore, it is essential for us to study the local immune response by using tumor-infiltrating T-lymphocytes (TITL) and not just simply the easily accessible peripheral blood lymphocytes (PBL) of the patients (5,6). Our previous reports of a high enrichment of virusspecific HLA-restricted T-cells at the site of inflammation during the acute phase of viral infections was
Experimental Protocol
In vivo activated TITL were always directly cloned and expanded without any prior in vitro restimulation with lymphoma cells but in the presence of phytohemagglutinin (PHA); we therefore may assume that no selection for certain subpopulations or certain specificities occurred before the cloning procedure, and random growth of TITL could be expected (5, 6) . As not all ex- panded T-cell populations were monoclonal in the strict sense of the word, the term TCL will be used. The growing TCLs were analyzed for proliferating frequency by using Lefkovits calculation and were analyzed for phenotype by using monoclonal antibodies specific for T-cell subpopulations (CD3, CD4, CD8) and HLA-DR. TCLs were analyzed for function by using conventional cytotoxicity assays and analyzed for specific reactivity by using proliferation assays against the malignant B-cells and the autoantigens actin, cardiolipin (phospholipid), and various tumor-associated glycolipids (GM1, GDla, GTl, Ll-A). Southern Blot analyses were carried out using conventional techniques (8) .
Results
The analysis of B-cell lymphoma-infiltrating T-cells revealed patterns of reactivity as far as proliferating frequency, phenotype, functions, antigen-specificities, and restriction elements were concerned that were almost identical to our previous observations in patients with chronic viral infections, autoimmune diseases (Table 1), and gastric carcinomas (7, 9, 10) . In 6 patients with B-cell lymphomas of various subtypes, about 1 in 50 T-cells gave rise to a TCL (proliferating frequency 0.02) (Fig. 1) ; they all were CD3+. As compared to normal PBL, all of which grow under these culture conditions (11),' this poor response to PHA indicates a reduced proliferative capacity of the TITL. A substantial HLA-DR+ fraction of TITL had obviously been activated in vivo. There is a predominance of CD4+ T-cells in the infiltrate. The CD4/CD8 ratio was 3.8:1 before and after cloning, suggesting that there is no selection for certain subpopulations due to our cloning procedure. Out of 45 TCLs analyzed so far from one patient with B-cell lymphoma of the lung, 4 were cytotoxic as shown by their ability to exert lectin-dependent cytotoxicity (LDCC) against allogeneic target cells. Of these, 3 demonstrated cytotoxicity specific for the autologous malignant B-cells (2 of which were CD4+ the NK-sensitive K562 cell line in a HLA-unrestricted manner. All TCLs were also tested for proliferative reactivity to the autologous lymphoma cells, but only four TCLs (CD4+) responded with a 3.3-, 3.5-, 6.0-, and 66-fold 3H-TdR incorporation (Table 2) . When tested against tumor-associated glycolipids, five TCLs (CD4+) reacted to the autoantigenic ganglioside GM, with stimulation indices of 3.3 x, 4.5 x, 5.0 x, 5.2 x, and 8.8 x ( Table  2) . Though not identified sufficiently in this study, the restriction elements are most likely class II HLA molecules.
Using cells directly after isolation from the lymphoma tissue (-35% TITL), Southern Blot analyses did not reveal a clonal TcR gene rearrangement within all TITL populations (sensitivity :3%). The PBL of all lymphoma patients showed a drastically reduced response to mitogens (PHA, Concavalin A, pokeweed mitogen) ( Table  3) .
Discussion
The present report describes for the first time the establishment of TCLs directly from surgically resected (14) (15) (16) . Therefore, cloning TITL may be the only means of investigating the specificity of these CD4+ T-cell populations and of finding out whether they respond to tumor-associated autoantigens (e.g., glycolipids, glycoproteins). In order to maintain self-tolerance, such ubiquitous autoantigens, known to be highly expressed on certain tumor cell surfaces, have to be protected by the immune system. Consequently, they would have to induce T-suppressor cells (probably the CD4+ TITL population) that would facilitate oncogenesis by suppressing antitumor (anti-self) reactivity (14) (15) (16) . Allowing malignant cells to escape from the immune system would be an important way by which immune effectors could produce tumor progression.
